Lv5
890 积分 2021-08-05 加入
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
2小时前
待确认
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
3小时前
待确认
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
6小时前
待确认
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1个月前
已完结
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1个月前
已完结
Encorafenib/binimetinib induced severe liver injury in a melanoma patient: Case report and review of literature
1个月前
已完结
Encorafenib overdose
1个月前
已完结
Demystifying BRAF Mutation Status in Colorectal Liver Metastases
3个月前
已完结
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
3个月前
已完结
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study
3个月前
已完结
皖公网安备34019202002308
